Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03907
Species: Homo sapiens
Position : chr11:111343838-111451584
Year: 2013
Title: Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.
Genome Build: hg38
Enhancer Type: Super-enhancer
Condition: Disease
Disease Name: diffuse large B-cell lymphoma
PMID:  24332044
MONDO: MONDO:0018905
Tissue: bone marrow
Tissue Ontology ID: UBERON:0002371
Cell Source: OCI-Ly1
CVCL ID: CVCL_1879
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Super-enhancer identification; Functional perturbation assay; Drug perturbation assay
High Throughput Method: H3K27ac ChIP-seq; BRD4 ChIP-seq; BCL6 ChIP-seq; RNA polymerase II ChIP-seq; gene expression microarray
Low Throughput Method: JQ1 BET inhibition; POU2AF1 shRNA knockdown; POU2AF1 rescue/overexpression; RT-qPCR; Western blot; proliferation assay; apoptosis assay; xenograft assay
About Target Gene
Target gene : POU2AF1
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg38) 1 found
Enhancer ID Position Tissue Cell Disease
E_03927 chr11:111357554-111446979 peritoneal fluid malignant cell diffuse large B-cell lymphoma
Expression of Target Genes for the Enhancer